A Dose Escalating Study to Determine the Tolerability and PK of a Single Dose of Androxal
Clinical trial NCT01959685 · COMPLETED
Trial details
- NCT number
- NCT01959685
- Sponsor
- Repros Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2013-11-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.